Drug interactions
Indacaterol-glycopyrronium + Rimantadine
Severity: Minor
Indacaterol-glycopyrronium and Rimantadine: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Rimantadine can cause CNS effects such as dizziness, insomnia and nervousness, and has some anticholinergic-type adverse effects. Inhaled glycopyrronium has low systemic exposure, so a meaningful additive effect is unlikely and the interaction is poorly established.
What this interaction means in plain words
Indacaterol-glycopyrronium and Rimantadine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Indacaterol-glycopyrronium belongs to Respiratory; Rimantadine belongs to Anti Virals.
Why it happens
Theoretical additive central or anticholinergic effects; no established mechanism with the low systemic exposure of inhaled glycopyrronium.
What to do
No routine action is needed. Review the patient if new confusion, dry mouth or urinary retention appears.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Indacaterol-glycopyrronium and Rimantadine, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Rimantadine
Frequently asked questions
Can I take Indacaterol-glycopyrronium with Rimantadine?
MediHelp rates the interaction as minor. Indacaterol-glycopyrronium and Rimantadine have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Rimantadine can cause CNS effects such as dizziness, insomnia and nervousness, and has some anticholinergic-type adverse effects. Inhaled glycopyrronium has low systemic exposure, so a meaningful additive effect is unlikely and the interaction is poorly established.
How serious is the interaction between Indacaterol-glycopyrronium and Rimantadine?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No routine action is needed. Review the patient if new confusion, dry mouth or urinary retention appears.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
